Aphelion Capital

What is Aphelion Capital?

Aphelion Capital is a venture capital firm which was incorporated in 2005 to invest in ideas, entrepreneurs and companies with medical technologies to improve the quality and efficiency of healthcare delivery. The firm is based in Mill Valley, California. Aphelion Capital is a healthcare venture capital firm investing in capital efficient products and services that improve patient outcomes at the same or lower cost to the healthcare system.

They invest in early and mid stage medical device and digital health companies with passionate leaders dedicated to solving today's healthcare problems.

They have established a number of strategic relationships to provide their portfolio companies with the resources they need to thrive in the healthcare ecosystem and work diligently to provide them support. Strategic Partners include a network established to enhance the value of their investments.

Aphelion Capital's focus on the intersection of healthcare and technology positions them at the forefront of the industry's transformation. With an investment thesis that underlines the importance of cost-effective solutions that drive value and improve outcomes, Aphelion aims to back companies that align with the pressing needs of patients, providers, and payers.

The firm's specialties in Seed, Startup, Early Stage, Expansion, Later Stage, PIPE, Series A, and Series B funding round connote their flexibility and breadth of investment stages. Their investments range from a minimum of $100,000 to a maximum of $5,000,000, with $1,500,000 being their sweet spot for funding.

By structuring their portfolio across various sectors such as BioTech, FinTech & Financial Services, HealthTech & Fitness, Analytics, Medical Devices & Hospital Services, Healthcare & Wellness, Consumer, Pharmaceutical & Medicine, they exhibit a multi-faceted approach to healthcare innovation.